A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo

被引：9
|
作者：
Lund, LH
Wahren, B
Garcia-Blanco, MA
机构：
[1] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17182 Solna, Sweden
[4] Karolinska Inst, Swedish Inst Infect Dis Control, S-17182 Solna, Sweden
来源：
JOURNAL OF GENERAL VIROLOGY | 2003年 / 84卷
关键词：
D O I：
10.1099/vir.0.18645-0
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Human immunodeficiency virus type 1 (HIV-1) Tat and human Cyclin T1 form a complex and together recognize the viral TAR RNA element with specificity. Using HIV-1/equine infectious anaemia virus TAR chimeras, we show that in addition to the well-characterized interaction with the bulge, Tat recognizes the distal stem and the loop of TAR. These data support previously proposed, but unproven, molecular models.
引用
收藏
页码：603 / 606
页数：4
相关论文
共 50 条
  • [21] An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
    Hamy, F.
    Felder, E. R.
    Heizmann, G.
    Lazdins, J.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (08):
  • [22] An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
    Hamy, F
    Felder, ER
    Heizmann, G
    Lazdins, J
    AboulEla, F
    Varani, G
    Karn, J
    Klimkait, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3548 - 3553
  • [23] Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
    Kotler, M
    Simm, M
    Zhao, YS
    Sova, P
    Chao, W
    Ohnona, SF
    Roller, R
    Krachmarov, C
    Potash, MJ
    Volsky, DJ
    JOURNAL OF VIROLOGY, 1997, 71 (08) : 5774 - 5781
  • [24] Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro
    Ji, XD
    Klarmann, GJ
    Preston, BD
    BIOCHEMISTRY, 1996, 35 (01) : 132 - 143
  • [25] In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity
    Celeghini, C
    Marchisio, M
    Mischiati, C
    Bertolaso, L
    Capitani, S
    Zauli, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) : 349 - 354
  • [26] MAPPING OF HIV-1 TAT PROTEIN SEQUENCES REQUIRED FOR BINDING TO TAR RNA
    KAMINE, J
    LOEWENSTEIN, P
    GREEN, M
    VIROLOGY, 1991, 182 (02) : 570 - 577
  • [27] Genetic subtypes of human immunodeficiency virus type 1 (HIV-1) in Istanbul, Turkey
    Yilmaz, Gulden
    Midilli, Kenan
    Turkoglu, Salih
    Bayraktaroglu, Zubeyir
    Kuskucu, A. Mert
    Ozkan, Emine
    Atasever, Leman
    Calangu, Semra
    Altas, Kemal
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 (04) : 286 - 290
  • [28] Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 Suppression
    Nugent, C. Thomas
    Nodelman, Vladislav
    Giachetti, Cristina
    Richman, Douglas D.
    Looney, David J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (03) : 833 - 836
  • [29] Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 gag vaccination
    Balamurugan, Arumugam
    Lewis, Martha J.
    Kitchen, Christina M. R.
    Robertson, Michael N.
    Shiver, John W.
    Daar, Eric S.
    Pitt, Jacqueline
    Ali, Ayub
    Ng, Hwee L.
    Currier, Judith S.
    Yang, Otto O.
    JOURNAL OF VIROLOGY, 2008, 82 (06) : 2784 - 2791
  • [30] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
    TILL, M
    MACDONELL, KB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
12345